药物

研究阶段

乳腺癌

Exemestane + everolimus

Phase III (randomized trial)

Advanced breast cancer (hormone-receptor-positive) [24]

Temsirolimus

Phase II

Metastatic breast cancer [25]

Tamoxifen + everolimus

Phase II (randomized trial)

Metastatic breast cancer [26]

Plustrastuzumab + vinorelbine + everolimus

Phase III

HER2-positivebreast cancer [27]

Trastuzumab + ridaforolimus

Phase IIb

Trastuzumab-refractory metastatic breast cancer (human epidermal growth factor receptor 2-positive) [28]

Paclitaxel + trastuzumab + everolimus

Phase II

Advanced breast cancer (HER-2 positive) [29]